- Home
- ULY vs TTNP Comparison
ULY vs TTNP Comparison
Compare ULY & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULY
- TTNP
- Stock Information
- Founded
- ULY 2013
- TTNP 1991
- Country
- ULY United States
- TTNP United States
- Employees
- ULY N/A
- TTNP 4
- Industry
- ULY
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ULY
- TTNP Health Care
- Exchange
- ULY Nasdaq
- TTNP Nasdaq
- Market Cap
- ULY 7.4M
- TTNP 5.9M
- IPO Year
- ULY N/A
- TTNP 1996
- Fundamental
- Price
- ULY $5.72
- TTNP $4.40
- Analyst Decision
- ULY Strong Buy
- TTNP
- Analyst Count
- ULY 1
- TTNP 0
- Target Price
- ULY $12.00
- TTNP N/A
- AVG Volume (30 Days)
- ULY 1.3M
- TTNP 44.6K
- Earning Date
- ULY 08-11-2025
- TTNP 08-14-2025
- Dividend Yield
- ULY N/A
- TTNP N/A
- EPS Growth
- ULY N/A
- TTNP N/A
- EPS
- ULY N/A
- TTNP N/A
- Revenue
- ULY $134,085,000.00
- TTNP N/A
- Revenue This Year
- ULY N/A
- TTNP N/A
- Revenue Next Year
- ULY $23.08
- TTNP N/A
- P/E Ratio
- ULY N/A
- TTNP N/A
- Revenue Growth
- ULY N/A
- TTNP N/A
- 52 Week Low
- ULY $2.99
- TTNP $3.03
- 52 Week High
- ULY $22.50
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- ULY 53.94
- TTNP 48.35
- Support Level
- ULY $4.00
- TTNP $4.23
- Resistance Level
- ULY $9.42
- TTNP $4.65
- Average True Range (ATR)
- ULY 0.80
- TTNP 0.27
- MACD
- ULY 0.34
- TTNP -0.03
- Stochastic Oscillator
- ULY 41.70
- TTNP 30.67
About ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.